State Ledger
Company profile

Prelude Therapeutics Inc CIK 1678660

Ticker
PRLD (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, DE 19805
Fiscal year end
2025 (FY)
Market Data
Close
$3.22
Change
-$0.33
Change %
-9.31%
Volume
29,785

PRLD · trading date Oct 14, 2026 · previous close $3.55 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$12.14M
Net income
-$99.50M
Total assets
$141.32M
Total liabilities
$72.68M
Stockholders' equity
$68.64M
Cash & equivalents
$35.26M
Operating income
-$104.57M
Operating cash flow
-$56.30M
Capital expenditures
$67.0K

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-861.3%
Net margin
-819.6%
Free cash flow
-$56.37M
Free cash flow margin
-464.3%
Liabilities / assets
51.4%
Equity / assets
48.6%
CapEx / revenue
0.6%
Operating cash flow / net income
0.57×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $12.14M -$99.50M $141.32M $72.68M $68.64M
2024 $7.00M -$127.17M $175.52M $44.06M $131.46M
2023 — -$121.83M $277.67M $40.58M $237.09M
2022 — -$115.44M $220.50M $25.06M $195.44M
2021 — -$111.69M $305.10M $19.20M $285.90M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-10
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Wilmington, DE 19805
175 INNOVATION BOULEVARD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:23 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Delaware — Public Companies